What medicine is used to treat malignant uterine fibroids?

What medicine is used to treat malignant uterine fibroids? The treatment of malignant uterine fibroids has always been the focus of medical attention. Malignant uterine fibroids refer to a malignant tumor that occurs in the smooth muscle tissue of the uterus and is highly invasive and metastatic. For this disease, the medical community currently mainly uses comprehensive treatment methods, including surgical resection, radiotherapy, chemotherapy and targeted therapy, to improve the patient's survival rate and quality of life.

Surgical resection is the preferred method for treating malignant uterine fibroids. It can not only directly remove the tumor, but also clarify the condition and stage, and provide an effective basis for subsequent radiotherapy and chemotherapy. The surgery generally uses total hysterectomy or hysterectomy plus bilateral adnexectomy. The doctor will choose the appropriate surgical method according to the severity of the lesion and the patient's condition. Surgical resection can completely remove the tumor tissue and prevent its further spread and metastasis.

Radiotherapy is also an important treatment for malignant uterine fibroids. It uses high-energy rays to kill tumor cells. Radiotherapy is usually performed after surgery to remove residual tumor cells and prevent recurrence and metastasis. Radiotherapy helps improve the patient's survival rate and improve postoperative symptoms.

Chemotherapy is the use of anti-tumor drugs to kill tumor cells. In the treatment of malignant uterine fibroids, chemotherapy is often combined with surgery and radiotherapy to increase the effectiveness of treatment. Commonly used chemotherapy drugs include paclitaxel and platinum drugs, which can interfere with the division and growth of tumor cells, thereby achieving a therapeutic effect.

In addition, targeted therapy is also a development direction for the treatment of malignant uterine fibroids. Targeted drugs can target specific targets of tumor cells, interfere with their growth and replication process, and thus inhibit the growth and spread of tumors. In recent years, some targeted drugs such as ramucirumab have been used clinically and have achieved certain therapeutic effects.

In short, the treatment of malignant uterine fibroids requires comprehensive consideration of the patient's age, condition, pathological classification and other factors, and the use of a comprehensive treatment method including surgery, radiotherapy, chemotherapy and targeted therapy. Scientific and rational selection of treatment plans, early detection and diagnosis, and adherence to treatment are the key to improving patient survival and quality of life.

【Popular Science Introduction】

Uterine fibroids are benign tumors of the uterine myometrium. According to statistics, the incidence of uterine fibroids in women is about 30%-50%, among which the risk of malignant transformation of uterine fibroids is relatively low. Malignant uterine fibroids are relatively rare, but they are relatively invasive and metastatic. Uterine fibroids are mainly divided into two types: benign and malignant. The treatment of malignant uterine fibroids is more complicated and difficult. Therefore, the treatment of malignant uterine fibroids needs to be carried out in a timely manner, and early detection and selection of appropriate treatment plans are required to improve the treatment effect and the patient's survival rate.